Warning: fopen(/home/virtual/colon/journal/upload/ip_log/ip_log_2026-01.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96
, Samuel Avoine, Sébastien Drolet
, François Letarte, Alexandre Bouchard, Jean-Pierre Gagné
, Claude Thibault
, Roger C. Grégoire, Naomee Jutras Bouthillette, Maude Gosselin, Philippe Bouchard Department of Surgery, Laval University, Québec, QC, Canada
Copyright © 2023 The Korean Society of Coloproctology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this Article
| Variable | IA group | EA group | P-value |
|---|---|---|---|
| No. of patients | 64 | 221 | |
| Age (yr) | 71 ± 10 | 71 ± 10 | 0.83 |
| Sex | 0.89 | ||
| Male | 35 (54.7) | 123 (55.7) | |
| Female | 29 (45.3) | 98 (44.3) | |
| ASA PS classification | 0.26 | ||
| I | 4 (6.3) | 19 (8.6) | |
| II | 40 (62.5) | 138 (62.4) | |
| III | 17 (26.6) | 62 (28.1) | |
| IV | 3 (4.7) | 2 (0.9) | |
| Charlson comorbidity index | 6.3 ± 2.7 | 5.9 ± 3.0 | 0.28 |
| Body mass index (kg/m2) | 28.0 ± 6.3 | 27.2 ± 4.9 | 0.35 |
| Corticosteroids | 8 (12.5) | 17 (7.7) | 0.22 |
| Smoking | 12 (18.8) | 29 (13.1) | 0.31 |
| Diabetes | 19 (29.7) | 53 (24.0) | 0.41 |
| Malnutrition | 3 (4.7) | 17 (7.7) | 0.58 |
| Anemia |
29 (45.3) | 95 (43.0) | 0.76 |
| History of intraabdominal surgery | 38 (59.4) | 107 (48.4) | 0.16 |
| History of abdominal hernia | 6 (9.4) | 11 (5.0) | 0.23 |
| History of radiotherapy | 3 (4.7) | 11 (5.0) | > 0.99 |
| Variable | IA group (n = 64) | EA group (n = 221) | P-value |
|---|---|---|---|
| Surgical indication | 0.36 | ||
| Neoplasm | 40 (62.5) | 153 (69.2) | |
| Polyp | 24 (37.5) | 68 (30.8) | |
| Lesion location | < 0.01 | ||
| Caecum | 33 (51.6) | 51 (23.1) | |
| Ascending colon | 18 (28.1) | 139 (62.9) | |
| Hepatic flexure | 12 (18.8) | 23 (10.4) | |
| Appendix | 1 (1.6) | 8 (3.6) | |
| Extraction site |
< 0.01 | ||
| Midline/periumbilical | 2 (3.1) | 112 (51.4) | |
| Off-midline | 62 (96.9) | 106 (48.6) | |
| Transverse | 45 (70.3) | 100 (45.9) | |
| Pfannenstiel | 17 (26.6) | 1 (0.5) | |
| Paramedian | 0 (0) | 3 (1.4) | |
| Left lower quadrant | 0 (0) | 2 (0.9) |
| Variable | IA group (n = 64) | EA group (n = 221) | P-value |
|---|---|---|---|
| Pathological diagnosis |
0.41 | ||
| Adenocarcinoma | 39 (60.9) | 137 (62.0) | |
| Adenoma | 22 (34.4) | 76 (34.4) | |
| Others | 3 (4.7) | 8 (3.6) | |
| Pathological T stage |
0.85 |
||
| 0 | 0 (0) | 2 (1.5) | |
| 1 | 4 (10.0) | 23 (16.8) | |
| 2 | 7 (17.5) | 22 (16.0) | |
| 3 | 25 (62.5) | 75 (54.7) | |
| 4 | 4 (10.0) | 15 (11.0) | |
| Pathological N stage |
0.96 |
||
| 0 | 27 (67.5) | 96 (70.1) | |
| 1 | 9 (22.5) | 27 (19.7) | |
| 2 | 4 (10.0) | 14 (10.2) | |
| Perforation | 0 (0) | 2 (1.0) | > 0.99 |
| Positive margin | 0 (0) | 0 (0) | NA |
| Invasion | |||
| Lymphovascular | 14 (21.9) | 55 (25.2) | 0.77 |
| Venous | 10 (15.6) | 30 (13.8) | 0.66 |
| Perinervous | 6 (9.4) | 11 (5.1) | 0.23 |
| Margin | |||
| Proximal | 13.0 ± 6.7 | 14.7 ± 8.4 | 0.10 |
| Distal | 19.9 ± 8.3 | 17.5 ± 8.1 | 0.04 |
| Lymph node | |||
| Total removed | 32 ± 11 | 30 ± 13 | 0.33 |
| Positive | 0.6 ± 1.5 | 0.6 ± 1.6 | 0.91 |
| Variable | IA group (n = 64) | EA group (n = 221) | P-value |
|---|---|---|---|
| Operative time (min) | 160 ± 31 | 138 ± 42 | < 0.01a |
| Blood loss (mL) | 41 ± 43 | 53 ± 69 | 0.09a |
| Blood transfusion | 1 (1.6) | 2 (0.9) | 0.54 |
| Intraoperative complication | 3 (4.7) | 19 (8.6) | 0.43 |
| Time to first flatus (day) | 2 (2–3) | 2 (1–3) | 0.05b |
| Time to first bowel movement (day) | 3 (2–4) | 3 (2–4) | 0.17b |
| Ileus | 11 (17.2) | 20 (9.0) | 0.07 |
| Nasogastric tube insertion | 11 (17.2) | 43 (19.5) | 0.86 |
| Length of stay (day) | 4 (3–6) | 4 (3–6) | 0.41b |
| Anastomotic complicationd | |||
| Leak | 0 (0) | 5 (2.3) | 0.59c |
| Bleeding | 2 (3.1) | 6 (2.7) | > 0.99c |
| Stenosis | 0 (0) | 0 (0) | NAc |
| Intraabdominal abscess | 0 (0) | 1 (0) | > 0.99c |
| Surgical reoperationd | 0 (0) | 2 (0.9) | > 0.99c |
| Rehospitalizationd | 5 (7.8) | 13 (5.9) | 0.55c |
| Surgical site infectione | 3 (4.7) | 5 (2.3) | 0.38c |
| Incisional herniaf | 1 (1.6) | 25 (11.3) | 0.01c |
| Clinical diagnosis | 0 (0) | 19 (8.6) | 0.01c |
| Radiological diagnosis | 1 (1.6) | 12 (5.4) | 0.31c |
| Incisional hernia repairf | 1 (1.6) | 9 (4.1) | 0.47c |
| Incisional hernia | IA group (n = 64) |
EA group (n = 218) |
P-value |
|---|---|---|---|
| Midline/periumbilical | 0/2 (0) | 15/112 (13.4) | 0.19 |
| Transverse | 0/45 (0) | 10/100 (10.0) | |
| Pfannenstiel | 1/17 (5.9) | 0/1 (0) | |
| Paramedian | 0/0 (0) | 0/3 (0) | |
| Left lower quadrant | 0/0 (0) | 0/2 (0) |
| Parameter |
HR (95% CI) | P-value |
|---|---|---|
| Anastomosis technique (IA vs. EA) | 7.13 (0.96–53.17) | 0.06 |
| Body mass index | 1.07 (0.99–1.15) | 0.08 |
| Corticosteroid intake | NA | 0.11 |
| Diabetes | NA | 0.16 |
| Incision extraction site (midline vs. off-midline) | NA | 0.36 |
| Variable | IA group (n = 39) | EA group (n = 137) | P-value |
|---|---|---|---|
| Recurrence | 2 (5.1) | 17 (12.4) | 0.25 |
| Type of recurrence |
|||
| Anastomotic | 0 (0) | 1 (0.7) | > 0.99 |
| Regional | 0 (0) | 2 (1.5) | > 0.99 |
| Distant metastasis | 2 (5.1) | 16 (11.7) | 0.37 |
Values are presented as number only, mean±standard deviation, or number (%). IA, intracorporeal anastomosis; EA, extracorporeal anastomosis; ASA, American Society of Anesthesiology; PS, physical status. Defined as hemoglobin level of <120 g/L.
Values are presented as number (%). IA, intracorporeal anastomosis; EA, extracorporeal anastomosis. Significance determined by Fisher exact test. Missing data for 3 patients in the EA group (n=218).
Values are presented as number (%) or mean±standard deviation. IA, intracorporeal anastomosis; EA, extracorporeal anastomosis; NA, not applicable. Including patients with adenocarcinoma, and 1 patient with a neuroendocrine tumor in the IA group. Significance determined by Fisher exact test. Significance determined by t-test procedure.
Values are presented as mean±standard deviation, number (%), or median (interquartile range). IA, intracorporeal anastomosis; EA, extracorporeal anastomosis; NA, not applicable. Significance determined by at-test procedure, bMann-Whitney U-test, and cFisher’s exact test. Incidence proportion dwithin 30 days postoperatively, ewithin 90 days postoperatively, and fat end of follow-up in June 2020.
Values are presented as number (%). IA, intracorporeal anastomosis; EA, extracorporeal anastomosis. Incidence proportion (hernia/number of incisions) at end of follow-up in June 2020. Significance determined by Fisher exact test.
HR, hazard ratio; CI, confidence interval; IA, intracorporeal anastomosis; EA, extracorporeal anastomosis; NA, not applicable. Some variables not included in the model with higher P-values are not shown. Significance determined by the chi-square test.
Values are presented as number (%). IA, intracorporeal anastomosis; EA, extracorporeal anastomosis. Significance determined by Fisher exact test. Some patients had multiple types of recurrence.